19 Results
Sort By:
Published on April 17, 2024
With the aim of bringing more real world data to cancer care, Flatiron Health and the National Comprehensive Cancer Network (NCCN) have renewed their collaboration to allow more cancer centers access to Flatiron’s curated data sets, and thus better evaluate and enhance the quality of care given at their sites.…
Published on September 23, 2022
Molecular testing company Caris Life Sciences announced today a partnership with cancer-focused technology company Flatiron Health to integrate the ordering and delivery of results of its oncology molecular tests with Flatiron’s OncoEMR, a cloud-based electronic medical record. By integrating with OncoEMR, Caris will extend the reach of its molecular profiling…
Published on February 12, 2021
Precision medicine biotech company H3 Biomedicine Inc. announced last week a partnership with Flatiron Health, and Foundation Medicine to use of real-world data in its research and development potential new, targeted cancer drugs. “The valuable insights we derive from our unique real-world data set can play a pivotal role in…
Published on April 10, 2019
A study published yesterday in Journal of the American Medical Association offers validation that real-world data obtained from routine clinical care to generate a multi-institution clinico-genomic database is feasible and can yield novel, clinically meaningful insights, Foundation Medicine and Flatiron Health said. Researchers from the two Roche subsidiaries joined collaborators…
Published on February 16, 2018
Flatiron Health, a healthcare technology and services company whose offerings are designed to support cancer-care providers and life science companies, would be acquired by Roche for $1.9 billion under a deal designed to expand the buyer’s presence in precision medicine and oncology. Flatiron Health has developed the OncologyCloud software suite, whose…
Published on November 3, 2016
Sifting for clues to cancer by combining genomic and clinical data is the goal of a new information platform launched today by healthcare technology developer Flatiron Health and oncology-focused molecular information company Foundation Medicine. The companies have co-developed the Clinico-Genomic Database, an information platform designed to help researchers and biopharmas speed…
Published on October 17, 2024
Physicians will now be able to order Myriad Genetics’ MyRisk® Hereditary Cancer Test and view the results of the test directly in Flatiron Health’s cloud-based electronic medical record (EMR) platform, OncoEMR. MyRisk is the first hereditary cancer test to be incorporated into Flatiron’s OncoEMR. Myriad is a genetic testing pioneer,…
Published on September 13, 2018
Three founding oncology practices have announced the launch of OneOncology, a technology driven platform to help community cancer centers provide high-quality across the continuum of care for the more than 50 percent of cancer patients who receive treatment at rural oncology practices. “With the launch of OneOncology, we hope to…
Published on January 18, 2024
LunaDNA, once heralded as “the world’s first member-owned data-sharing platform for health research,” is to close on January 31, 2024. The San Diego company made the news official with a statement on its website. Earlier this month, the company had sent an email to customers with the headline “Luna is…
Published on February 10, 2023
An explosion in big data is sweeping through the healthcare space, and biopharma companies are eager to capitalize on abundant clinical data from the real world, or real-world evidence (RWE). These five RWE providers are attracting big investments for their potential to streamline precision healthcare and boost drug development. For…
Published on July 22, 2021
Startup Orchid is launching the first preconception test that the company contends predicts a couple’s chances of conceiving a child with high risk of common illnesses, such as heart disease, stroke, schizophrenia, and several types of cancer. The test applies whole-genome sequencing (WGS) to a saliva sample from each partner,…
Published on September 28, 2020
The very first woman to make a breakthrough that has influenced precision medicine was Rosalind Franklin via the famous Photo 51, an x-ray defraction image taken under her direction by one of her graduate students that showed the exquisite structure of DNA. Shown to James Watson without her knowledge, the…
Published on July 15, 2019
David FitzPatrick’s typical patient is a toddler with global developmental delay who is small for her age, has epilepsy, and cannot speak or understand speech. Often there is no family history of similar symptoms and the parents will report no problems with the pregnancy and birth. The child will have…
Published on June 27, 2019
A new study confirms that multi-gene panel testing is cost-effective compared to single-marker testing, but could deliver more value if patients received the targeted therapy indicated by the test results. In the study, which was published 22 June 2019 in JCO Clinical Cancer Informatics,researchers estimated the cost effectiveness of managing therapeutic…
Published on May 15, 2019
(L-R) Ramesh Durvasula, PhD, of Eli Lilly; Paolo Guarnieri, MD, of Boehringer Ingelheim; Sarah Kramarz of Flatiron Health; and Karen Akinsanya, PhD, of Schrodinger discuss challenges to widespread biopharma adoption of artificial intelligence during a panel discussion at the 2019 Annual Meeting of NewYorkBIO, held yesterday…